Unknown

Dataset Information

0

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.


ABSTRACT: Activity-dependent neuroprotective protein (ADNP), essential for brain formation, was discovered as a leading de novo mutated gene causing the autism-like ADNP syndrome. This syndrome is phenotypically characterized by global developmental delays, intellectual disabilities, speech impediments, and motor dysfunctions. The Adnp haploinsufficient mouse mimics the human ADNP syndrome in terms of synapse density and gene expression patterns, as well as in developmental, motor, and cognitive abilities. Peripheral ADNP was also discovered as a biomarker for Alzheimer's disease and schizophrenia, with nasal administration of the ADNP snippet peptide NAP (enhancing endogenous ADNP activity) leading to partial cognitive and functional protection at the cellular, animal and clinical settings. Here, a novel formulation for effective delivery of NAP is provided with superior brain penetration capabilities. Also provided are methods for treating pertinent clinical implications such as autism, cognitive impairments, olfactory deficits, and muscle strength using the formulation in the Adnp haploinsufficient mouse. Results showed a dramatically specific increase in brain/body bioavailability with the new formulation, without breaching the blood brain barrier. Additional findings included improvements using daily intranasal treatments with NAP, at the behavioral and brain structural levels, diffusion tensor imaging (DTI), translatable to clinical practice. Significant effects on hippocampal and cerebral cortical expression of the presynaptic Slc17a7 gene encoding vesicular excitatory glutamate transporter 1 (VGLUT1) were observed at the RNA and immunohistochemical levels, explaining the DTI results. These findings tie for the first time a reduction in presynaptic glutamatergic synapses with the autism/Alzheimer's/schizophrenia-linked ADNP deficiency coupled with amelioration by NAP (CP201).

SUBMITTER: Sragovich S 

PROVIDER: S-EPMC6341082 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.

Sragovich Shlomo S   Malishkevich Anna A   Piontkewitz Yael Y   Giladi Eliezer E   Touloumi Olga O   Lagoudaki Roza R   Grigoriadis Nikolaos N   Gozes Illana I  

Translational psychiatry 20190115 1


Activity-dependent neuroprotective protein (ADNP), essential for brain formation, was discovered as a leading de novo mutated gene causing the autism-like ADNP syndrome. This syndrome is phenotypically characterized by global developmental delays, intellectual disabilities, speech impediments, and motor dysfunctions. The Adnp haploinsufficient mouse mimics the human ADNP syndrome in terms of synapse density and gene expression patterns, as well as in developmental, motor, and cognitive abilities  ...[more]

Similar Datasets

| S-EPMC2198899 | biostudies-literature
| S-EPMC7732499 | biostudies-literature
| S-EPMC3326387 | biostudies-literature
2010-04-06 | E-GEOD-10923 | biostudies-arrayexpress
| S-EPMC6203613 | biostudies-literature
| S-EPMC3563690 | biostudies-literature
2010-03-01 | GSE10923 | GEO